---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-002107"
form_type: "8-K"
ticker: "DXR"
cik: "0000027367"
company_name: "DAXOR CORP"
filed_at: "2022-01-24T23:59:59+00:00"
generated_at: "2026-06-27T16:20:08.203655+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Daxor appoints Caleb DesRosiers to Board of Directors

## Summary
- Caleb DesRosiers, JD, MPA, appointed to Board effective January 18, 2022, until next annual meeting.
- Currently senior principal at Valuate Healthcare (part of Omnicom); previously Chief Strategy Officer at PrescribeWellness.
- Board determined Mr. DesRosiers meets NYSE independence standards and qualifies under Regulation S-K Item 407(a).
- He has no beneficial ownership of Daxor stock or rights to acquire stock as of appointment date.
- Will receive standard non-employee director compensation as described in the company's proxy statement.

## SEC filing metadata
- accession: 0001493152-22-002107
- form_type: 8-K
- ticker: DXR
- cik: 0000027367
- company_name: DAXOR CORP
- filed_at: 2022-01-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/27367/000149315222002107/0001493152-22-002107-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/27367/000149315222002107/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-002107
- JSON: https://secwatch.observer/filing/0001493152-22-002107.json
- Plain text: https://secwatch.observer/filing/0001493152-22-002107.txt

## Key facts
- Executive change
  Caleb DesRosiers was appointed as Director at DAXOR CORP.
  - Action: appointed
  - Role: Director
  source text: On January 18, 2022, Caleb DesRosiers, JD, MPA was appointed to the Board of Directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/27367/000149315222002107/0001493152-22-002107-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.